ArticleBlood and lymphatic cancer : targets and therapy2017

Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies.

Theodoros Karantanos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.